Acadia Healthcare Company (ACHC) Gains from Sales and Divestitures (2012 - 2026)

Acadia Healthcare Company has disclosed Gains from Sales and Divestitures across 15 years of filings, most recently posting $56425.0 for Q1 2026.

• In Q1 2026, Gains from Sales and Divestitures fell 15.37% year-over-year to $56425.0; the TTM figure through Mar 2026 stood at $56425.0 (down 15.37% YoY), while the FY2025 annual figure was $457275.0, up 364.22% from the prior year.
• Gains from Sales and Divestitures fell to $56425.0 in Q1 2026, from $457275.0 in the prior quarter.
• Over the last five years, Gains from Sales and Divestitures for ACHC reached as high as $1.4 million in Q2 2023 and fell as low as $56425.0 in Q1 2026.
• The 5-year median for Gains from Sales and Divestitures is $342259.0 (2024), against an average of $416894.5.
• Annual changes were most pronounced in 2024 — Gains from Sales and Divestitures plunged 93.0% — and 2025, when it surged 364.22%.
• A 5-year view of Gains from Sales and Divestitures shows it stood at $518474.0 in 2022, then fell by 22.23% to $403223.0 in 2023, then tumbled by 75.57% to $98504.0 in 2024, then surged by 364.22% to $457275.0 in 2025, then plunged by 87.66% to $56425.0 in 2026.
• According to Business Quant data, Gains from Sales and Divestitures over the past three periods registered $56425.0, $457275.0, and $66676.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.